The Clinical Value of the Nitric Oxide System Components in Asthma and COPD

NCT04456491 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2023-07-21

No results posted yet for this study

Summary

It is planned to conduct a study of nitric oxide metabolites (nitrates and nitrites), L-arginine, arginase-1, and asymmetric dimethylarginine in patients with bronchial asthma and chronic obstructive pulmonary disease, followed by observation to assess the prognosis of the disease.

Conditions

Sponsors & Collaborators

  • Ryazan State Medical University

    lead OTHER

Principal Investigators

  • Anton Shakhanov, MD, Cand.Sci. (Med.) · Ryazan State Medical University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • Russia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04456491 on ClinicalTrials.gov